I agree that this site is using cookies. You can find further informations here.
X
Bodrogi, I.
43  results:
Search for persons X
?
1

SATRAPLATIN (S) INCREASES PROGRESSION-FREE SURVIVAL (PFS) A..:

Sternberg, N. ; Sartor, O.A. ; Petrylak, D.P....
European Urology Supplements.  7 (2008)  3 - p. 230 , 2008
Link: https://doi.org/10.1016/..
 
?
2

A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE II STUDY..:

Horti, J. ; Widmark, A. ; Stenzl, A....
European Urology Supplements.  7 (2008)  3 - p. 231 , 2008
Link: https://doi.org/10.1016/..
 
?
3

Phase I study of TZT-1027, a novel synthetic dolastatin 10 ..:

Horti, J. ; Juhasz, E. ; Monostori, Z....
Cancer Chemotherapy and Pharmacology.  62 (2008)  1 - p. 173-180 , 2008
Link: https://doi.org/10.1007/..
 
?
4

4010 POSTER Satraplatin increases progression-free survival..:

Sternberg, C. ; Sartor, O. ; Petrylak, D....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 282 , 2007
Link: https://doi.org/10.1016/..
 
?
5

4502 ORAL Phase 2 study of irinotecan and cisplatin in epid..:

Theodore, C. ; Skoneczna, I. ; Bodrogi, I....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 299 , 2007
Link: https://doi.org/10.1016/..
 
?
6

HER-2/neu as a Predictive Marker in a Population of Advance..:

Di Leo, A. ; Chan, S. ; Paesmans, M....
Breast Cancer Research and Treatment.  86 (2004)  3 - p. 197-206 , 2004
Link: https://doi.org/10.1023/..
 
?
7

883 Expression and clinical relevance of the lung resistanc..:

Mandoky, L. ; Geczi, L. ; Doleschall, Z....
European Journal of Cancer Supplements.  1 (2003)  5 - p. S266 , 2003
Link: https://doi.org/10.1016/..
 
?
8

992 Human phase II/A study of a novel somatostatin analogue..:

Gyergyay, F. ; Gödény, M. ; Szüts, T....
European Journal of Cancer Supplements.  1 (2003)  5 - p. S297 , 2003
Link: https://doi.org/10.1016/..
 
?
9

Clinical characteristics, treatment and outcome of patients..:

Geczi, L. ; Gomez, F. ; Bak, M..
European Journal of Cancer.  37 (2001)  - p. S225 , 2001
Link: https://doi.org/10.1016/..
 
?
10

PET reveals increased metabolic activity of the spinal cord..:

Esik, O. ; Bodrogi, I. ; Csere, T....
International Journal of Radiation Oncology*Biology*Physics.  51 (2001)  3 - p. 236-237 , 2001
Link: https://doi.org/10.1016/..
 
?
11

Long term effect of oral testosterone substitution therapy ..:

Horti, J. ; Petranyi, A. ; Forgacs, S..
European Journal of Cancer.  37 (2001)  - p. S224-S225 , 2001
Link: https://doi.org/10.1016/..
 
?
12

Environmental or hereditary risk of cancer in testicular tu..:

Gundy, S. ; Babosa, M. ; Baki, M..
European Journal of Cancer.  37 (2001)  - p. S223 , 2001
Link: https://doi.org/10.1016/..
 
?
13

A randomized phase II trial assessing irinotecan (IRI) and ..:

Pozzo, C. ; Pyrhönen, S. ; Bodrogi, I....
European Journal of Cancer.  35 (1999)  - p. S70 , 1999
Link: https://doi.org/10.1016/..
 
?
14

Testicular self-examination (TSE) and testicular ultrasound..:

Géczi, L. ; Bodrogi, I.
European Journal of Cancer.  35 (1999)  - p. S347 , 1999
Link: https://doi.org/10.1016/..
 
?
15

Significance of examination of prostate-specific antigen an..:

Romics, I. ; Frang, D. ; Bodrogi, I.
International Urology and Nephrology.  29 (1997)  4 - p. 449-455 , 1997
Link: https://doi.org/10.1007/..
 
1-15